The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics' oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness.
from https://ift.tt/3wey1RX
Subscribe to:
Post Comments (Atom)
Multiple bomb and arson attacks rock southern Thailand
Explosions and fires ripped through at least 17 locations in southern Thailand on Wednesday, authorities said, in what appeared to be multip...
-
Tanzania's women football team have reacted following comments from Tanzania's female President Samia Suluhu Hassan describing femal...
-
The pandemic may have brought work to a halt on projects around the world, but next year is nonetheless set to welcome an exciting array of ...
-
The State Department on Tuesday ordered the departure of government employees from the US Embassy in Kabul "whose functions can be perf...
No comments:
Post a Comment